Trial Profile
Follow-up Safety Trial in Children With Chronic Heart Failure Therapy Receiving Orodispersible Minitablets of Enalapril
Status:
Not yet recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Enalapril (Primary)
- Indications Heart failure
- Focus Adverse reactions
- Acronyms ENALONG; LENA-WP10
- Sponsors Ethicare GmbH
- 20 Sep 2018 This trial has been completed in Austria.
- 20 Sep 2018 This trial has been completed in Austria.
- 20 Sep 2018 This trial has been completed in Hungary .